Ratio de rendimiento sobre el capital contable (ROE)
desde 2005

Abbott Laboratories, ROE, tendencias a largo plazocálculo

	ROE	=	100	×	Ganancias netas¹	÷	Inversión total de los accionistas de Abbott¹
31 dic 2024	28.12%	=	100	×	13,402)	÷	47,664)
31 dic 2023	14.83%	=	100	×	5,723)	÷	38,603)
31 dic 2022	18.90%	=	100	×	6,933)	÷	36,686)
31 dic 2021	19.75%	=	100	×	7,071)	÷	35,802)
31 dic 2020	13.71%	=	100	×	4,495)	÷	32,784)
31 dic 2019	11.86%	=	100	×	3,687)	÷	31,088)
31 dic 2018	7.76%	=	100	×	2,368)	÷	30,524)
31 dic 2017	1.54%	=	100	×	477)	÷	30,897)
31 dic 2016	6.82%	=	100	×	1,400)	÷	20,538)
31 dic 2015	20.85%	=	100	×	4,423)	÷	21,211)
31 dic 2014	10.61%	=	100	×	2,284)	÷	21,526)
31 dic 2013	10.23%	=	100	×	2,576)	÷	25,171)
31 dic 2012	22.32%	=	100	×	5,963)	÷	26,721)
31 dic 2011	19.35%	=	100	×	4,728)	÷	24,440)
31 dic 2010	20.66%	=	100	×	4,626)	÷	22,388)
31 dic 2009	25.14%	=	100	×	5,746)	÷	22,856)
31 dic 2008	27.92%	=	100	×	4,881)	÷	17,480)
31 dic 2007	20.28%	=	100	×	3,606)	÷	17,779)
31 dic 2006	12.22%	=	100	×	1,717)	÷	14,054)
31 dic 2005	23.39%	=	100	×	3,372)	÷	14,415)

¹ US$ en millones

Abbott Laboratories, ROE, tendencias a largo plazo, comparación con los competidores

	Abbott Laboratories	CVS Health Corp.	Elevance Health Inc.	Intuitive Surgical Inc.	Medtronic PLC	UnitedHealth Group Inc.
31 dic 2024	28.12%	6.11%	14.47%	14.13%	7.32%	15.55%
31 dic 2023	14.83%	10.91%	15.23%	13.51%	7.30%	25.22%
31 dic 2022	18.90%	5.84%	16.59%	11.98%	9.59%	25.87%
31 dic 2021	19.75%	10.54%	16.93%	14.32%	7.01%	24.09%
31 dic 2020	13.71%	10.35%	13.77%	10.90%	9.44%	23.52%
31 dic 2019	11.86%	10.39%	15.15%	16.69%	9.25%	24.02%
31 dic 2018	7.76%	-1.02%	13.14%	16.89%	6.12%	23.19%
31 dic 2017	1.54%	17.57%	14.50%	13.97%	8.01%	22.10%
31 dic 2016	6.82%	14.44%	9.84%	12.74%	6.80%	18.33%
31 dic 2015	20.85%	14.08%	11.11%	13.63%	5.03%	17.18%
31 dic 2014	10.61%	12.23%	10.60%	12.39%	15.76%	17.31%
31 dic 2013	10.23%	12.10%	10.05%	19.16%	18.57%	17.50%
31 dic 2012	22.32%	10.28%	11.16%	18.34%	21.14%	17.72%
31 dic 2011	19.35%	9.10%	11.36%	18.71%	19.39%	18.17%
31 dic 2010	20.66%	9.09%	12.12%	18.74%	21.18%	17.94%
31 dic 2009	25.14%	10.33%	19.09%	15.13%	16.88%	16.19%
31 dic 2008	27.92%	9.29%	11.62%	16.13%	19.34%	14.33%
31 dic 2007	20.28%	8.42%	14.55%	16.26%	25.53%	23.20%
31 dic 2006	12.22%	13.80%	12.59%	12.22%	27.14%	19.99%
31 dic 2005	23.39%	14.70%	9.86%	21.27%	17.26%	18.61%

Abbott Laboratories, ROE, tendencias a largo plazo, en comparación con el sector industrial: health care equipment & services

	Abbott Laboratories	Health Care Equipment & Services
31 dic 2024	28.12%	13.71%
31 dic 2023	14.83%	15.59%
31 dic 2022	18.90%	15.27%
31 dic 2021	19.75%	15.49%
31 dic 2020	13.71%	14.35%
31 dic 2019	11.86%	14.41%
31 dic 2018	7.76%	9.60%
31 dic 2017	1.54%	13.23%
31 dic 2016	6.82%	11.47%
31 dic 2015	20.85%	12.32%
31 dic 2014	10.61%	13.38%
31 dic 2013	10.23%	13.66%
31 dic 2012	22.32%	15.91%
31 dic 2011	19.35%	14.75%
31 dic 2010	20.66%	15.08%
31 dic 2009	25.14%	16.80%
31 dic 2008	27.92%	14.94%
31 dic 2007	20.28%	16.53%
31 dic 2006	12.22%	16.33%
31 dic 2005	23.39%	16.05%

Abbott Laboratories, ROE, tendencias a largo plazo, en comparación con la industria: health care

Abbott Laboratories (NYSE:ABT)